Dyno Therapeutics launches Dyno-yp2, a top-performing TfR1-mediated AAV capsid, to further diversify CNS delivery portfolio ...
Recent research has identified a specific biological mechanism that may explain why females experience more severe ...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced ...
Adjusted EBITDA -- $1.1 million for the period, compared to an adjusted loss of $1.4 million in the same quarter last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback